| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/20/2008 | WO2008032757A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family with enhanced expression of the alsabc operon |
| 03/20/2008 | WO2008032748A1 Transgenic silkworm capable of producing functional antibody molecule |
| 03/20/2008 | WO2008032712A1 Monoclonal antibody and use thereof |
| 03/20/2008 | WO2008032693A1 Material for control of soil-borne disease in plant utilizing novel filamentous bacterium |
| 03/20/2008 | WO2008032659A1 Secretion signal peptide having improved efficiency, and method for production of protein by using the same |
| 03/20/2008 | WO2008032574A1 TRACE mRNA AMPLIFICATION METHOD AND USE THEREOF |
| 03/20/2008 | WO2008032287A2 Regulation of sucrose content and/or cell wall composition in sugarcane |
| 03/20/2008 | WO2008032058A2 Method for sequencing a polynucleotide |
| 03/20/2008 | WO2008032053A1 Fhr-4a splicing variants |
| 03/20/2008 | WO2008032035A1 Expression of tgf-beta in plastids |
| 03/20/2008 | WO2008031899A2 Oligonucleotide non-viral delivery systems |
| 03/20/2008 | WO2008031854A2 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2008031746A1 Animal model for the selection and validation of agents active against pulmonary emphysema and colorectal cancer |
| 03/20/2008 | WO2008031598A1 Nuclear transport agent and method for producing said agent |
| 03/20/2008 | WO2008031569A1 Means for increasing intracellular levels of protoporphyrin ix and use thereof |
| 03/20/2008 | WO2008031430A2 Doubly transgenic non-human mammal |
| 03/20/2008 | WO2008031331A1 A recombinant adenovirus target-oriented coexpressing human p53 and p53aip1 |
| 03/20/2008 | WO2008031257A1 A percussion-controlling device of gene gun |
| 03/20/2008 | WO2008031226A1 Mammalian oocyte development competency granulosa markers and uses thereof |
| 03/20/2008 | WO2008016317A3 A sequence of dsrna: atn-rna, intervention using irnai, use of a sequence of dsrna: atn-rna, a method of treating and inhibiting a brain tumor, a kit for inhibiting cancer cell which expresses tenascin, a method for a kit preparation in a brain tumor therapy |
| 03/20/2008 | WO2008010840A3 Fsh mutants |
| 03/20/2008 | WO2008009565A3 Method for screening an enhancer or a masker of salty taste |
| 03/20/2008 | WO2008003656A3 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| 03/20/2008 | WO2007145894A3 A rapid method to determine inhibitor sensitivity of ns3/4a protease sequences |
| 03/20/2008 | WO2007141540A3 Rk2-based broad-host-range cloning vector useful for transfer of metagenomic libraries to a variety of bacterial species |
| 03/20/2008 | WO2007137700A3 Mutated dna-polymerases with higher selectivity |
| 03/20/2008 | WO2007137114A3 Artificial plant minichromosomes |
| 03/20/2008 | WO2007136646A3 Delta5 desaturase and its use in making polyunsaturated fatty acids |
| 03/20/2008 | WO2007135386A3 Improvements in or relating to starch storage in plants |
| 03/20/2008 | WO2007133797A3 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
| 03/20/2008 | WO2007130521A3 Fermentive production of four carbon alcohols |
| 03/20/2008 | WO2007123771A3 Ige directed dna vaccination |
| 03/20/2008 | WO2007120883A3 Compositions and their uses directed to hepcidin |
| 03/20/2008 | WO2007115724A3 Method of increasing the in vivo recovery of therapeutic polypeptides |
| 03/20/2008 | WO2007113784A3 Methods for modulating the levels and effects of thyrotropin-releasing hormone (trh) and trh-related petides |
| 03/20/2008 | WO2007110600A3 Plant promoters, coding sequences and their uses |
| 03/20/2008 | WO2007092704A3 Genes for enhancing nitrogen utilization efficiency in crop plants |
| 03/20/2008 | WO2007084684A3 Therapeutic uses of inhibitors of rtp801 |
| 03/20/2008 | WO2007082164A3 Methods for identifying functional noncoding sequences |
| 03/20/2008 | WO2007067808A3 Immunogenic composition based on conditionally live virion and method for producing the same |
| 03/20/2008 | WO2007064857A8 Amphoteric liposome formulation |
| 03/20/2008 | WO2007060247A3 Enzyme preparations yielding a clean taste |
| 03/20/2008 | WO2006076741A3 Canine 5-hydroxytryptamine 2a and 2b receptor materials and thier use |
| 03/20/2008 | WO2005105840A3 Cd40 variants and uses thereof |
| 03/20/2008 | WO2001030965A3 Methods of in vivo gene transfer using a sleeping beauty transposon system |
| 03/20/2008 | WO2001025398A3 Process for inducing functional tolerance to gene transfer products |
| 03/20/2008 | WO2000058489A3 Production of syringyl lignin in gymnosperms |
| 03/20/2008 | US20080072352 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same |
| 03/20/2008 | US20080072351 Fatty Acid Desaturases and Uses Thereof |
| 03/20/2008 | US20080072350 Polynucleotides encoding plant prenyl proteases |
| 03/20/2008 | US20080072349 Rubisco Activase with Increased Thermostability and Methods of Use Thereof |
| 03/20/2008 | US20080072348 Nucleic acid molecules and other molecules associated with plants |
| 03/20/2008 | US20080072347 Transcription factor stress-related proteins and methods of use in plants |
| 03/20/2008 | US20080072346 Wheat variety 26r87 |
| 03/20/2008 | US20080072345 Transgenic seeds for use in generating herbicide, insect and disease resistant crop plants with waxy starch |
| 03/20/2008 | US20080072344 Highly Transformable Elite Inbred Line-PHWWE |
| 03/20/2008 | US20080072343 Transgenic seeds for propagation of herbicide, insect, drought and disease resistant maize plants with enhanced culturability, phosphorus, antioxidants, carbohydrate and fatty acids metabolism |
| 03/20/2008 | US20080072342 Lettuce cultivar green thunder |
| 03/20/2008 | US20080072340 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 03/20/2008 | US20080071076 Non-invasive detection of fetal genetic traits |
| 03/20/2008 | US20080071075 siRNA targeting proteasome 26S subunit, non-ATPase, 10 (Gankyrin or PSMD10) |
| 03/20/2008 | US20080071073 siRNA targeting ubiquitin ligases |
| 03/20/2008 | US20080071072 Aqueous solution containing cationic stabilizer; plasmids; genomes; kits |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071068 Cytoplasmic Localization Dna and Rna |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070996 Transfers a D-glucuronic acid residue to an N-acetyl-D-galactosamine residue when the N-acetyl-D-galactosamine residue is present at the non-reducing end of the chondroitin backbone, or transfers an N-acetyl-D-galactosamine residue to a D-glucuronic acid residue |
| 03/20/2008 | US20080070858 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 03/20/2008 | US20080070854 Conserved Hbv and Hcv Sequences Useful for Gene Silencing |
| 03/20/2008 | US20080070853 Peptides Selectively Lethal to Malignant and Transformed Mammalian Cells |
| 03/20/2008 | US20080070840 Polypeptides or peptides modified to include at least one antibody Fc region and, optionally, one or more water soluble polymers; have ability to stimulate in vivo and in vitro production of platelets, and/or megakaryocytopoietic activity, i.e., the ability to stimulate production of platelet precursors |
| 03/20/2008 | US20080070837 Variants of human bone morphogenetic proteins and other cysteine knot cytokine proteins with improved properties, including increased expression yield, expression in absence of a pro-domain, increased solubility, increased specific activity, altered receptor, co-receptor, inhibitor specificity |
| 03/20/2008 | US20080070836 Zinc transporter LIV1 can be used as an epithelial-mesenchymal transition (EMT) regulatory agent; further, because EMT is involved in cancer progression, LIV1 antisense nucleotides and the like may be used as pharmaceuticals for treating cancer |
| 03/20/2008 | US20080070835 Hla-Dr-Binding Antigen Peptide Derived From Wt1 |
| 03/20/2008 | US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 03/20/2008 | US20080070829 Family of pesticidal proteins and methods for their use |
| 03/20/2008 | US20080070306 Genetically modified plant comprising transcription factor sequences for enhancing efficacy of exogenous gene expression |
| 03/20/2008 | US20080070305 Inhibition of expression of a target gene |
| 03/20/2008 | US20080070300 Human chemotactic cytokine |
| 03/20/2008 | US20080070299 Synthetic nucleic acid molecule compositions and methods of preparation |
| 03/20/2008 | US20080070298 Promoter of Synoviolin Gene |
| 03/20/2008 | US20080070297 Regulatory elements for delivery to the liver |
| 03/20/2008 | US20080070296 Expression vector comprising argobacterium sequences for use as tool in efficient heterologous gene transfer; disease, stress, insect and herbicide resistant plants; biological pest control |
| 03/20/2008 | US20080070291 Nucleotide sequences coding chlorophyllase for use in preparation of paper products, detergents and foods |
| 03/20/2008 | US20080070287 Transforming the Bacillus cell with a heterologous nucleotide sequence encoding a lipid acyltransferase, expressing the lipid acyltransferase in the cell, transforming the Bacillus licheniformis cell with a heterologous nucleotide sequence, expressing the lipid acyltransferase |
| 03/20/2008 | US20080070286 Dna Participating in Hydroxylation of Macrolide Compound |
| 03/20/2008 | US20080070279 Group of Synthetic Antimicrobal Peptides |
| 03/20/2008 | US20080070278 Immunoglobulin fusion comprising clostridial light chain for use in controlling interaction of particular cell types with their external environment; drug targeting and delivery |
| 03/20/2008 | US20080070277 Homologous Amds Genes as Selectable Marker |
| 03/20/2008 | US20080070276 Transcriptional Termination of Transgene Expression Using Host Genomic Terminators |
| 03/20/2008 | US20080070273 Culturing marine bacteria and isolating viricidal, bactericididal, fungicidal and antitumor agents from broths |
| 03/20/2008 | US20080070271 Function homology screening |
| 03/20/2008 | US20080070260 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080070255 Novel gene and uses therefor to modify pasture qualities of crops |
| 03/20/2008 | US20080070249 Peroxisome proliferator activator gamma coactivator-1 alpha (PGC-1 alpha ) for use as modulator of glucose transport; antidiabetic agents |
| 03/20/2008 | US20080070238 Method for the Synthesizing Nucleic Acids, and Application Thereof |
| 03/20/2008 | US20080070232 Expression Vectors Containing a Truncated Epstein Barr Nuclear Antigen 1 Lacking the Gly-Gly-Ala Domain for Enhanced Transient Gene Expression |